MolPort-001-615-062

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 25 USDMF, 4 CEP/COS, 6 JDMF, 17 EU WC, 34 KDMF, 27 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

666 FDF Dossiers, 178 FDA Orange Book, 274 Europe, 55 Canada, 46 Australia, 43 South Africa, 70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 200MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 150MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 16 SPI Pharma, 2 Seqens, 11 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 43 Direct Compression, 35 Controlled & Modified Release, 34 Thickeners and Stabilizers, 31 Disintegrants & Superdisintegrants, 30 Solubilizers, 29 Granulation, 27 Topical, 25 Parenteral, 23 Film Formers & Plasticizers, 23 Taste Masking, 21 Co-Processed Excipients, 20 Lubricants & Glidants, 15 Chewable & Orodispersible Aids, 13 Emulsifying Agents, 9 Empty Capsules, 9 API Stability Enhancers, 7 Rheology Modifiers, 7 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 62 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 247 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

18 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

137 US Patents, 4 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 205122 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 25MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TOPIRAMATE(UNII: 0H73WJJ391) (TOPIRAMATE - UNII:0H73WJJ391)	TOPIRAMATE	100mg

Inactive Ingredients

Ingredient Name	Glenmark Pharmaceuticals Inc., USA	NorthStar RxLLC	REMEDYREPACK INC.
AMMONIA(5138Q19F1X)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
D&C RED NO. 30(2S42T2808B)
DIETHYL PHTHALATE(UF064M00AF)
ETHYLCELLULOSE (10 MPA.S)(3DYK7UYZ62)
FD&C RED NO. 40(WZB9127XOA)
FD&C YELLOW NO. 5(I753WB2F1M)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4)
HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 6000(30IQX730WE)
POTASSIUM HYDROXIDE(WZH3C48M4T)
PROPYLENE GLYCOL(6DC9Q167V3)
SHELLAC(46N107B71O)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: MolPort-001-615-062